Bicara Therapeutics BCAX Voting rights, votes per share
Voting rights, votes per share at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept bcax:CommonStockVotingRightsVotesPerShare.
The source filing: Bicara Therapeutics’s 10-K, filed March 30, 2026.
- Filed
- Mar 30, 2026, 12:00 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001628280-26-022010
The Company has 500,000,000 shares of Common Stock authorized for issuance with par value $0.0001 per share. As of December 31, 2025 and 2024, 56,600,724 and 54,444,180 shares were issued, net of share repurchased and cancellation, respectively and 56,600,724 shares and 54,440,013 shares, net were outstanding, respectively. The holder of each share of common stock is entitled to one vote per share. The common shareholders are entitled to dividends whenever funds and assets are legally available, but only when, as and if declared by the board of directors of the Company.
Item 16. Form 10-K Summary
FAQ
- What is Bicara Therapeutics's voting rights, votes per share?
- Bicara Therapeutics (BCAX) reported voting rights, votes per share of 0.3 in Q4 2025.
- What does voting rights, votes per share mean?
- This metric defines the number of votes a single share of common stock is entitled to cast during shareholder meetings. It is a key indicator of corporate governance and the distribution of control among shareholders. Understanding this helps investors evaluate the influence of equity holders over company decision-making.
Ask your AI about Bicara Therapeutics's voting rights, votes per share.
Connect your AI assistant and compare it to peers, right in your chat.
